BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20015684)

  • 1. Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage.
    Raymond S; Delobel P; Mavigner M; Cazabat M; Souyris C; Encinas S; Bruel P; Sandres-Sauné K; Marchou B; Massip P; Izopet J
    J Clin Virol; 2010 Feb; 47(2):126-30. PubMed ID: 20015684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current tests to evaluate HIV-1 coreceptor tropism.
    Rose JD; Rhea AM; Weber J; Quiñones-Mateu ME
    Curr Opin HIV AIDS; 2009 Mar; 4(2):136-42. PubMed ID: 19339953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic assays for the determination of coreceptor tropism in HIV-1 infected individuals.
    Braun P; Wiesmann F
    Eur J Med Res; 2007 Oct; 12(9):463-72. PubMed ID: 17933728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism.
    Raymond S; Delobel P; Mavigner M; Cazabat M; Souyris C; Sandres-Sauné K; Cuzin L; Marchou B; Massip P; Izopet J
    AIDS; 2008 Sep; 22(14):F11-6. PubMed ID: 18753930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists.
    Seclén E; Garrido C; González Mdel M; González-Lahoz J; de Mendoza C; Soriano V; Poveda E
    J Antimicrob Chemother; 2010 Jul; 65(7):1486-92. PubMed ID: 20427374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between genotypic (V3 population sequencing) and phenotypic (Trofile ES) methods of characterizing co-receptor usage of HIV-1 from 200 treatment-naïve HIV patients screened for Study A4001078.
    Portsmouth S; Valluri SR; Däumer M; Thiele B; Valdez H; Lewis M; Craig C; Thielen A; James I; Demarest J; Heera J
    Antiviral Res; 2013 Jan; 97(1):60-5. PubMed ID: 23165088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996-2007: the French ANRS CO06 PRIMO Cohort Study.
    Frange P; Galimand J; Goujard C; Deveau C; Ghosn J; Rouzioux C; Meyer L; Chaix ML
    J Antimicrob Chemother; 2009 Jul; 64(1):135-41. PubMed ID: 19411680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.
    Garrido C; Roulet V; Chueca N; Poveda E; Aguilera A; Skrabal K; Zahonero N; Carlos S; García F; Faudon JL; Soriano V; de Mendoza C
    J Clin Microbiol; 2008 Mar; 46(3):887-91. PubMed ID: 18199789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordance between two phenotypic assays and ultradeep pyrosequencing for determining HIV-1 tropism.
    Saliou A; Delobel P; Dubois M; Nicot F; Raymond S; Calvez V; Masquelier B; Izopet J;
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2831-6. PubMed ID: 21464245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists.
    Poveda E; Seclén E; González Mdel M; García F; Chueca N; Aguilera A; Rodríguez JJ; González-Lahoz J; Soriano V
    J Antimicrob Chemother; 2009 May; 63(5):1006-10. PubMed ID: 19261623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotyping methods for determining HIV tropism and applications in clinical settings.
    Raymond S; Delobel P; Izopet J
    Curr Opin HIV AIDS; 2012 Sep; 7(5):463-9. PubMed ID: 22832712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy.
    Raymond S; Saliou A; Delobel P; Cazabat M; Pasquier C; Jeanne N; Sauné K; Massip P; Marchou B; Izopet J
    J Antimicrob Chemother; 2014 Sep; 69(9):2527-30. PubMed ID: 24840625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic amino acid residues in the V3 loop of simian immunodeficiency virus envelope alter viral coreceptor tropism and infectivity but do not allow efficient utilization of CXCR4 as entry cofactor.
    Meister S; Otto C; Papkalla A; Krumbiegel M; Pöhlmann S; Kirchhoff F
    Virology; 2001 Jun; 284(2):287-96. PubMed ID: 11384227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of HIV-1 coreceptor tropism prediction by employing selected nucleotide positions of the env gene in a Bayesian network classifier.
    Díez-Fuertes F; Delgado E; Vega Y; Fernández-García A; Cuevas MT; Pinilla M; García V; Pérez-Álvarez L; Thomson MM
    J Antimicrob Chemother; 2013 Jul; 68(7):1471-85. PubMed ID: 23511232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of HIV-1 coreceptor tropism in clinical practise.
    Foeglein A; Walter H
    Eur J Med Res; 2007 Oct; 12(9):473-82. PubMed ID: 17933729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism.
    Whitcomb JM; Huang W; Fransen S; Limoli K; Toma J; Wrin T; Chappey C; Kiss LD; Paxinos EE; Petropoulos CJ
    Antimicrob Agents Chemother; 2007 Feb; 51(2):566-75. PubMed ID: 17116663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression plasmids are only useful for the investigation of co-receptor tropism and fusion capacity of short HIV-1 envelope domains.
    Grund S; Klein A; Adams O
    J Virol Methods; 2010 Jun; 166(1-2):106-9. PubMed ID: 20304009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV coreceptor phenotyping in the clinical setting.
    Low AJ; Swenson LC; Harrigan PR
    AIDS Rev; 2008; 10(3):143-51. PubMed ID: 18820716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The design and validation of a novel phenotypic assay to determine HIV-1 coreceptor usage of clinical isolates.
    Lin NH; Negusse DM; Beroukhim R; Giguel F; Lockman S; Essex M; Kuritzkes DR
    J Virol Methods; 2010 Oct; 169(1):39-46. PubMed ID: 20599562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.